ENDRA Life Sciences (NDRA) Gains from Investment Securities (2019 - 2026)
ENDRA Life Sciences (NDRA) reported Gains from Investment Securities of $8857.0 for Q1 2026, up 102.17% year-over-year from $4381.0 in Q1 2025, and up 107.63% quarter-over-quarter from -$116137.0 in Q4 2025.
ENDRA Life Sciences (NDRA) Gains from Investment Securities (2019 - 2026) Analysis & Trends
ENDRA Life Sciences (NDRA) has 8 years of Gains from Investment Securities data on file, last reported at $8857.0 in Q1 2026.
- Gains from Investment Securities for Q1 2026 came in at $8857.0, up 102.17% year-over-year; the trailing twelve-month figure through Mar 2026 was $3.4 million (up 1839.31% YoY), and the FY2025 annual result was $236.0, changed 0.0% from the prior year.
- Gains from Investment Securities advanced to $8857.0 in Q1 2026 per NDRA's latest filing, from -$116137.0 in the prior quarter.
- Over five years, Gains from Investment Securities peaked at $8.0 million in Q3 2022 and troughed at -$3.3 million in Q3 2024.
- A 5-year average of $1.9 million and a median of $389972.0 in 2022 frame the typical range for Gains from Investment Securities.
- The sharpest annual moves came in 2022 and 2024: Gains from Investment Securities soared 2302.49% in 2022, then sank 1319.08% in 2024.
- A 5-year view of Gains from Investment Securities shows it stood at $505816.0 in 2022, then sank by 45.8% to $274128.0 in 2023, then surged by 1332.27% to $3.9 million in 2024, then sank by 102.96% to -$116137.0 in 2025, then soared by 107.63% to $8857.0 in 2026.
- Business Quant data shows NDRA's Gains from Investment Securities at $8857.0 in Q1 2026, -$116137.0 in Q4 2025, and $266.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Waters | 30,529.42 Bn | 30,528.96 Bn | 1.11 Bn |
| 2 | Thermo Fisher Scientific | 183.75 Bn | 180.50 Bn | 7.74 Bn |
| 3 | Danaher | 133.13 Bn | 127.43 Bn | 3.59 Bn |
| 4 | Idexx Laboratories | 46.14 Bn | 45.94 Bn | 722.74 Mn |
| 5 | Agilent Technologies | 38.20 Bn | 36.39 Bn | 990.00 Mn |
| 6 | Natera | 31.50 Bn | 30.40 Bn | 696.04 Mn |
| 7 | Iqvia Holdings | 31.34 Bn | 29.36 Bn | 1.36 Bn |
| 8 | Illumina | 24.51 Bn | 23.36 Bn | 721.00 Mn |
| 9 | Mettler Toledo International | 23.53 Bn | 23.47 Bn | 555.82 Mn |
| 10 | ENDRA Life Sciences | 5.24 Mn | 4.89 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8,857.00 |
| Mar 31, 2026 | 8,857.00 |
| Dec 31, 2025 | -116,137.00 |
| Dec 31, 2025 | -116,137.00 |
| Sep 30, 2025 | 266.00 |
| Sep 30, 2025 | 266.00 |
| Jun 30, 2025 | 266.00 |
| Jun 30, 2025 | 266.00 |
| Mar 31, 2025 | -408,562.00 |
| Mar 31, 2025 | -408,562.00 |
| Dec 31, 2024 | 3.93 Mn |
| Dec 31, 2024 | 3.93 Mn |
| Sep 30, 2024 | -3.34 Mn |
| Sep 30, 2024 | -3.34 Mn |
| Jun 30, 2024 | 679,187.00 |
| Jun 30, 2024 | 679,187.00 |
| Sep 30, 2023 | 274,128.00 |
| Sep 30, 2023 | 274,128.00 |
| Jun 30, 2023 | 646,449.00 |
| Jun 30, 2023 | 646,449.00 |